Clinical trial
A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b
NCT00423644 · Alaunos Therapeutics, Industry · Unknown status
Key facts
| NCT number | NCT00423644 |
|---|---|
| Title | A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b |
| Official title | A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b |
| Lead sponsor | Alaunos Therapeutics, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Darinaparson |
| Enrollment | 17 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | Jan 18, 2007 |
| Last update posted | Nov 14, 2013 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: